CVR 37503312Entrepreneurial company (IVS)Konsulentbistand vedrørende informationsteknologi (620200)Aarhus CFounded 1 Mar 2016
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Apidemia IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
2
CVR registry, 2021
Gross profit
161K
DKK, annual report 2020
-50% on 2019
Result
-201.4K
DKK, annual report 2020
Equity
-1.1M
DKK, annual report 2020
Mara-Elena Somesan-Tarau100% of capital and votes, until 10 Nov 2022
Mara-Elena Somesan-Tarauuntil 11 Nov 2021
Equity was negative at 31 Dec 2020: -1.1M DKK. Dandex estimate, computed 6 Nov 2026.
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
100% of capital and votes2 Mar 2016 to 10 Nov 2022
Apidemia IVS holds no Danish company now.
Found by searching the CVR owner register (ejerregister) for Apidemia IVS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 3999177220% to under 25% of capital and votes1 Jan 2020 to 18 Mar 2022
CVR 4089632525% to under 33.3% of capital and votes24 Oct 2019 to 1 Feb 2021
CVR 3927493033.3% to under 50% of capital and votes24 Jan 2018 to 26 Oct 2020
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Sep 2021, monthly: 2 employees, 2 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| FTE | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Oct 2016 to Sep 2021.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Sep 2021, published 18 Nov 2021. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Gross profit | -105 | 243 | 211 | 322 | 161 |
| Operating profit | -262 | -371 | -331 | +57 | -136 |
| Result for the year | -262 | -384 | -355 | +60 | -201 |
| Equity | -262 | -646 | -1,001 | -941 | -1,142 |
| Total assets | 47 | 119 | 101 | 373 | 214 |
| Employees (average) | 1 | 2 | 2 | 1 | 2 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | Not reportednote 2 | -12.9% | 52.5% | -50% |
| EBITDA | Not reportednote 3 | Not reportednote 3 | Not reportednote 3 | 79 | -93 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | n.m.note 4 | Not reportednote 3 | Not reportednote 3 | 24.5% | -57.7% |
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | Not reportednote 2 | 0% | -50% | 100% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -26note 5 | -76note 5 | -48note 5 | 0 | -26 |
| Gearing, NIBD / EBITDA | Not reportednote 2 | Not reportednote 3 | Not reportednote 3 | 0x | n.m.note 6 |
| Capex (investeringer i anlægsaktiver) | Not reportednote 7 | Not reportednote 7 | Not reportednote 7 | 217note 8 | 0note 9 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -26note 5 | -76note 5 | -48note 5 | 25 | 0 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2016 covers 10 months (1 Mar to 31 Dec 2016). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2020
1 Jan 2020 to 31 Dec 2020, published 29 Jul 2021
Annual report 2019
1 Jan 2019 to 31 Dec 2019, published 3 Sep 2020
Annual report 2018
1 Jan 2018 to 31 Dec 2018, published 10 May 2019
Annual report 2017
1 Jan 2017 to 31 Dec 2017, published 2 Mar 2018
Annual report 2016
1 Mar 2016 to 31 Dec 2016, published 30 Jun 2017
Each registered value from the day it took effect, newest first.
From CVR, read 6 Nov 2026. Text such as the signing rule and purpose is shown as registered.
6 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Konkursbehandlingen afsluttet 10.11.2022, virksomheden opløst
Konkursdekret afsagt 11.11.2021 af Skifteretten i Aarhus
Direktion:
Fratrådte:
Mara-Elena Somesan, den 11.11.2021.
Revision:
Ny adresse: Filmbyen 23, 2. tv, 8000 Aarhus C
Ny adresse: Åbogade 15, 3. sal., 8200 Aarhus N
Ny kommune: Århus
Vedtægter ændret: 02.03.2016
Nyt navn: Apidemia IVS
Stiftelsesdato: 01.03.2016.
Virkningsdato: 01.03.2016.
Seneste vedtægtsdato: 01.03.2016.
Kapital:
kr. 1,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1,00 til kurs 100,00, fuldt indbetalt.
Stifter:
Mara-Elena Somesan, den 01.03.2016.
Direktion:
Mara-Elena Somesan, den 01.03.2016.
Selskabet tegnes af direktionen..
Første regnskabsår:
01.03.2016 - 31.12.2016.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udvikling, køb, salg og servicering af software og andre produkter og hermed beslægtet virksomhed.
1 registered in CVR.
P-number 1021210710Filmbyen 23, 8000 Aarhus C
